Table 2.
Evaluation of breast cell surface overexpressed genes according to ONCOMINE studies of grade, stage, and prognosis in breast tumors.
| Stage2 | Prognosis | |||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Grade1 | T | N | M | Survival3 | Disease-free survival4 | |||||||||||||||||||||||||||||||
| Bittner | Chin | Desmedt | Farmer | Finak | Ginestier | Hess | Kreike | Ma | Miller | Pollack | Sorlie | Sotiriou | Sotiriou | Zhao | Bittner | Sorlie | Sorlie | Bittner | Hess | Sorlie | Sorlie | Sotiriou | Turashvili | Yu | Sorlie | Bild | Desmedt | Pawitan | Sorlie | VandeVijver | Ma | Wang | Wang | Van de Vijver | VandeVijver | |
| SQLE | X | X | X | — | — | X | X | X | — | X | — | — | — | X | X | — | — | — | X | — | — | — | — | — | — | — | — | — | X | — | X | — | X | X | X | X |
| CNOT1 | X | X | X | X | — | X | X | — | — | X | — | — | — | X | — | — | — | — | — | — | — | — | — | — | — | — | — | — | X | — | X | — | X | X | — | — |
| TMEM132A | X | — | X | X | — | X | X | — | — | X | — | — | — | X | — | — | — | — | — | — | — | — | — | — | — | — | — | — | X | — | — | X | — | X | X | — |
| PTDSS1 | X | — | X | — | — | X | X | — | — | X | — | X | — | X | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | X | X | — | — | — | X | X |
| RPN2 | X | — | X | X | X | X | X | — | — | X | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | X | — | — | — | X | X |
| SLC2A1 | X | — | X | X | — | X | — | — | — | X | — | — | — | X | X | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | X | — | — | — | X | X |
| GPR172A | X | — | X | X | — | X | X | — | — | X | — | — | — | X | — | — | — | — | — | — | — | — | — | — | — | — | — | — | X | — | — | — | — | — | — | — |
| MMP15 | — | — | — | X | — | — | X | — | — | — | — | — | — | X | — | — | — | — | — | — | — | — | X | — | — | — | — | — | X | — | X | — | — | — | X | X |
| UNC93B1 | X | — | — | — | — | X | — | — | — | — | — | — | — | X | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | X | — | — | — | X | X |
| C6orf129 | X | — | — | — | — | X | — | — | X | — | — | — | — | — | X | — | — | — | — | — | — | — | — | — | — | — | — | — | X | — | — | — | — | — | — | — |
| NRM | X | — | — | — | — | X | — | — | X | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | X | — | — | — | X | — |
| SLC10A3 | X | — | — | — | — | — | — | — | — | X | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | X | — | — | — | X | X |
| CD72 | X | — | X | — | — | — | — | — | X | — | — | — | X | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| TNFRSF12A | X | — | — | — | — | X | — | — | — | X | — | — | — | — | — | — | — | — | — | — | — | — | X | — | — | — | — | — | — | — | — | — | — | — | — | — |
| IFI6 | X | — | — | — | — | — | — | X | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | X | X |
| BRI3 | X | — | — | — | — | — | — | — | — | — | — | — | — | — | X | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | X | — | — | — | X | — |
| SCARB1 | X | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | X | — | — | — | X | X |
| PERLD1 | — | X | — | — | — | — | X | — | — | X | — | — | — | X | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| TRPV2 | — | — | — | — | — | X | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | X | X | — | — | X | — |
| ORMDL3 | X | X | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | X | — | — | — | — | — | — | — |
| C19orf28 | X | — | — | — | — | X | — | — | — | — | — | — | — | — | X | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| PAQR4 | X | — | — | — | — | — | — | — | — | X | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | X | — | — | — | — | — | — | — |
| TM9SF1 | — | — | — | X | — | — | — | — | — | — | — | — | — | — | — | — | — | — | X | — | — | — | — | — | — | — | — | — | X | — | — | — | — | — | — | — |
| MMP14 | — | — | — | — | — | X | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | X | — | X | — | — | — |
| PTPRU | — | — | — | — | — | — | — | — | X | — | — | — | — | — | — | — | — | — | — | — | — | — | X | — | — | — | — | — | X | — | — | — | — | — | — | — |
| TMEM109 | X | — | — | X | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| P2RY11 | — | — | — | X | — | X | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| UPK1A | — | — | — | X | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | X | — | — | — | — |
| CADM4 | — | — | — | — | — | X | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | X | — | — | — | — | — | — | — |
| TYROBP | — | — | — | — | — | — | — | — | — | — | — | X | — | — | — | — | — | — | — | — | — | — | — | — | — | X | — | — | — | — | — | — | — | — | — | — |
| FXYD5 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | X | — | — | — | — | — | X | — | — | — | — | — |
| SPINT2 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | X | X |
| SYNGR2 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | X | X |
| TMPRSS4 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | X | X |
| ORAI1 | X | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ZDHHC12 | X | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| SDC4 | — | X | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| SDC3 | — | — | — | — | — | X | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| TMEM184B | — | — | — | — | — | X | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| TOR1AIP2 | — | — | — | — | — | — | — | — | X | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| TMEM147 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | X | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| TMED3 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | X | — | — | — | — | — | — | — | — |
| TREM2 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | X | — | — | — | — | — | — | — |
| SLC15A3 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | X | — | — | — | — | — |
| VSIG4 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | X | — | — | — | — | — |
| ANKH | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | X | — | — | — | — |
| ATP13A2 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | X | — | — | — | — |
| DEGS2 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | X | — | — | — | — |
| TNFRSF19 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | X | — | — | — | — |
| TMEM134 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | X | — | — |
1Compares lower with higher grade samples.
2Compares samples derived from Tn with Tn + x (T); Nx with Nx + 1 (N); and Mx with Mx + 1 (M).
3Compares samples derived from live and dead patients within 5 years.
4Compares samples derived from patients without and with relapse/recurrence in 5 years.
X: means overexpression in a given study (P < 0.01).